GlassScriptPhysician profile
Gene C Cheng
NPI 1417920232
$1,649.69
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $370 · 2021: $403 · 2022: $562.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $544.86 | 2019-2022 | |
| Abbvie INC. | $286.97 | 2021-2022 | |
| Avion Pharmaceuticals | $149.63 | 2022 | |
| Ucb, INC. | $106.36 | 2020-2022 | |
| Pfizer INC. | $71.67 | 2019 | |
| Csl Behring | $49.48 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $48.85 | 2019-2021 | |
| Biogen, INC. | $48.33 | 2020-2021 | |
| Lilly USA, LLC | $42.65 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $24.73 | 2021 | |
| Janssen Pharmaceuticals, INC | $23.18 | 2022 | |
| Merz North America, INC. | $22.75 | 2020 | |
| Acorda Therapeutics, INC | $21.98 | 2020 | |
| Sk Life Science, INC. | $21.38 | 2021 | |
| Corium, LLC | $19.97 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $19.32 | 2020 | |
| Sunovion Pharmaceuticals INC. | $19.21 | 2020 | |
| Neurocrine Biosciences, INC. | $18.92 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.75 | 2022 | |
| Kyowa Kirin, INC. | $18.23 | 2020 | |
| Adamas Pharmaceuticals, INC. | $16.25 | 2019 | |
| Emd Serono, INC. | $15.72 | 2019 | |
| Acadia Pharmaceuticals INC | $14.74 | 2021 | |
| Scilex Pharmaceuticals INC. | $13.81 | 2019 | |
| Supernus Pharmaceuticals, INC. | $11.95 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gene Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.